RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

Target & Classification

Virus:

RSVRespiratory syncytial virus

Type:

Live attenuated vaccine

Diseases:

Respiratory syncytial virus

Max Phase:

Phase 2

Phase 1

Phase 2

Phase 3

Approved

NCT ID	Phase	Disease / Condition
NCT00192478	Phase 2	Respiratory syncytial virus
NCT00345670	Phase 1	Respiratory syncytial virus
NCT00493285	Phase 1	Respiratory syncytial virus
NCT00686075	Phase 2	Respiratory syncytial virus